menu search

Astrazeneca (azn) set to acquire cincor pharma for $1.3b

AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiorenal...

January 10, 2023, 9:47 am

Baxter (bax) plans to form standalone kidney care company

Baxter (BAX) plans several strategic actions, including spin-off of renal Care and Acute Therapies glob...

January 9, 2023, 9:47 am

Astrazeneca to acquire cincor for us$1.8bn

AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for approximately US$1.8bn in an effort to boost its tr...

January 9, 2023, 7:09 am

Astrazeneca to buy cincor pharma in $1.8 billion deal

AstraZeneca said the deal, expected to close in the first quarter of 2023, will bolster its cardiorenal...

January 9, 2023, 4:32 am

Astrazeneca will buy u.s.-based cincor for cardiorenal asset

AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat cardio...

January 9, 2023, 2:29 am

: baxter stock drops on plan to restructure and spin off kidney care unit

Hospital products company shares drop as it readies a restructuring plan and sets plan to spin off its renal...

January 6, 2023, 1:40 pm

: baxter to spin off kidney care unit as part of a flurry of strategic actions

Baxter International Inc. BAX said Friday it plans to embark on a tax-free spin off to shareholders of its ren...

January 6, 2023, 12:17 pm

Baxter stock drops on plan to restructure and spin off kidney care unit

Baxter International Inc. said Friday it plans to embark on a tax-free spin off to shareholders of its renal<...

January 6, 2023, 8:40 am

Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism

Hyperkalemia is a common occurrence in patients with congestive heart failure, particularly when renal ...

January 3, 2023, 8:14 am

Biocryst to discontinue development of drug

Shares of BioCryst Pharmaceuticals Inc. were down about 5% in premarket trading on Thursday after the company said it halted development of BCX9930, w...

December 15, 2022, 8:52 am

renalytix plc (rnlx) q1 2023 earnings call transcript

renalytix Plc (NASDAQ:RNLX ) Q1 2023 Earnings Conference Call November 30, 2022 8:30 AM ET Company Part...

November 30, 2022, 1:26 pm

$fme : fresenius medical care enters monthly buying area

Fresenius Medical Care is a German American healthcare company. It is one of the four devisions of Fresenius SE & Co. KGaA. The company provides kidne...

November 21, 2022, 6:28 pm

Microsoft co-founder paul allen's art collection sells for an unprecedented $1.5 billion

The unprecedented $1.5 billion sale of the late Microsoft MSFT, +1.70% co-founder Paul Allen's masterpiece collection Wednesday evening at Christie's ...

November 12, 2022, 8:15 am

3 stocks that are screaming buys right now

Few things are more exhilarating than finding “screaming buys” in the stock market. When everything lines up and you know you're buying a stock at...

August 26, 2022, 12:17 pm

Merck (mrk) gets fda fast track tag for anticoagulant therapy

A phase II study is ongoing on Merck's (MRK) MK-2060 in people with end-stage renal disease receiving h...

August 24, 2022, 12:47 pm

renalytix: the investment case is shot

renalytix has a great product but a lousy cost base. I think that will force it to raise lots of new fu...

July 25, 2022, 2:16 am

Natera to present new signatera™ clinical data across multiple cancer types at the 2022 asco annual meeting

NSCLC:  ctDNA data in stage I-III patients showed 82% detection pre-treatment and was able to identify 100% of relapses prior to radiographic imaging...

May 31, 2022, 8:33 am


Search within

Pages Search Results: